These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

541 related items for PubMed ID: 10831005

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Once-daily fexofenadine treatment for chronic idiopathic urticaria: a multicenter, randomized, double-blind, placebo-controlled study.
    Kaplan AP, Spector SL, Meeves S, Liao Y, Varghese ST, Georges G.
    Ann Allergy Asthma Immunol; 2005 Jun; 94(6):662-9. PubMed ID: 15984599
    [Abstract] [Full Text] [Related]

  • 3. Once-daily fexofenadine HCl improves quality of life and reduces work and activity impairment in patients with seasonal allergic rhinitis.
    Meltzer EO, Casale TB, Nathan RA, Thompson AK.
    Ann Allergy Asthma Immunol; 1999 Oct; 83(4):311-7. PubMed ID: 10541423
    [Abstract] [Full Text] [Related]

  • 4. A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria.
    Finn AF, Kaplan AP, Fretwell R, Qu R, Long J.
    J Allergy Clin Immunol; 1999 Nov; 104(5):1071-8. PubMed ID: 10550755
    [Abstract] [Full Text] [Related]

  • 5. Safety and efficacy of oral fexofenadine in children with seasonal allergic rhinitis--a pooled analysis of three studies.
    Meltzer EO, Scheinmann P, Rosado Pinto JE, Bachert C, Hedlin G, Wahn U, Finn AF, Ruuth E.
    Pediatr Allergy Immunol; 2004 Jun; 15(3):253-60. PubMed ID: 15209959
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of fexofenadine hydrochloride for treatment of seasonal allergic rhinitis.
    Bernstein DI, Schoenwetter WF, Nathan RA, Storms W, Ahlbrandt R, Mason J.
    Ann Allergy Asthma Immunol; 1997 Nov; 79(5):443-8. PubMed ID: 9396979
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadine.
    LaForce CF, Corren J, Wheeler WJ, Berger WE, Rhinitis Study Group.
    Ann Allergy Asthma Immunol; 2004 Aug; 93(2):154-9. PubMed ID: 15328675
    [Abstract] [Full Text] [Related]

  • 8. Once-daily rupatadine improves the symptoms of chronic idiopathic urticaria: a randomised, double-blind, placebo-controlled study.
    Dubertret L, Zalupca L, Cristodoulo T, Benea V, Medina I, Fantin S, Lahfa M, Pérez I, Izquierdo I, Arnaiz E.
    Eur J Dermatol; 2007 Aug; 17(3):223-8. PubMed ID: 17478385
    [Abstract] [Full Text] [Related]

  • 9. Effect of 60 mg twice-daily fexofenadine HCl on quality of life, work and classroom productivity, and regular activity in patients with chronic idiopathic urticaria.
    Thompson AK, Finn AF, Schoenwetter WF.
    J Am Acad Dermatol; 2000 Jul; 43(1 Pt 1):24-30. PubMed ID: 10863219
    [Abstract] [Full Text] [Related]

  • 10. Multicenter study of the efficacy and safety of fexofenadine 60 mg. twice daily in 108 Thai patients with chronic idiopathic urticaria.
    Kulthanan K, Gritiyarangsan P, Sitakalin C, Charuwichitratana S, Korkij W, Aunhachoke K, Janjumratsang P, Jiamton S, Kuntiranont M, Krisadapong J, Gherunpong N, Kullavanijaya P.
    J Med Assoc Thai; 2001 Feb; 84(2):153-9. PubMed ID: 11336071
    [Abstract] [Full Text] [Related]

  • 11. [Chronic idiopathic urticaria: effectiveness of fexofenadine. A double-blind, placebo controlled study with 21 patients].
    Degonda M, Pichler WJ, Bircher A, Helbling A.
    Praxis (Bern 1994); 2002 Apr 10; 91(15):637-43. PubMed ID: 12014063
    [Abstract] [Full Text] [Related]

  • 12. Addition of fexofenadine to a topical corticosteroid reduces the pruritus associated with atopic dermatitis in a 1-week randomized, multicentre, double-blind, placebo-controlled, parallel-group study.
    Kawashima M, Tango T, Noguchi T, Inagi M, Nakagawa H, Harada S.
    Br J Dermatol; 2003 Jun 10; 148(6):1212-21. PubMed ID: 12828751
    [Abstract] [Full Text] [Related]

  • 13. Fexofenadine hydrochloride, 180 mg, exhibits equivalent efficacy to cetirizine, 10 mg, with less drowsiness in patients with moderate-to-severe seasonal allergic rhinitis.
    Hampel F, Ratner P, Mansfield L, Meeves S, Liao Y, Georges G.
    Ann Allergy Asthma Immunol; 2003 Oct 10; 91(4):354-61. PubMed ID: 14582814
    [Abstract] [Full Text] [Related]

  • 14. Safety of fexofenadine in children treated for seasonal allergic rhinitis.
    Graft DF, Bernstein DI, Goldsobel A, Meltzer EO, Portnoy J, Long J.
    Ann Allergy Asthma Immunol; 2001 Jul 10; 87(1):22-6. PubMed ID: 11476456
    [Abstract] [Full Text] [Related]

  • 15. Onset of action of fexofenadine hydrochloride 60 mg/pseudoephedrine hydrochloride 120 mg in subjects aged 12 years with moderate to severe seasonal allergic rhinitis: a pooled analysis of two single-dose, randomized, double-blind, placebo-controlled allergen exposure unit studies.
    Berkowitz RB, McCafferty F, Lutz C, Bazelmans D, Godfrey P, Meeves S, Liao Y, Georges G.
    Clin Ther; 2006 Oct 10; 28(10):1658-69. PubMed ID: 17157121
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Efficacy and tolerability of loratadine versus fexofenadine in the treatment of seasonal allergic rhinitis: a double-blind comparison with crossover treatment of nonresponders.
    Prenner BM, Capano D, Harris AG.
    Clin Ther; 2000 Jun 10; 22(6):760-9. PubMed ID: 10929922
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.